Is a big pharma LBO on the horizon?

With AstraZeneca’s CFO Jon Symonds leaving for Goldman Sachs, I wonder if it’s a sign we’ll see someone have a go at taking a big pharma company private. I wrote about the concept here.

June 13, 2007

Leave a Reply

Your email address will not be published. Required fields are marked *